Parallax Health Sciences (OTCMKTS:PRLX) & Illumina (NASDAQ:ILMN) Head to Head Review

Illumina (NASDAQ:ILMN) and Parallax Health Sciences (OTCMKTS:PRLX) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability and institutional ownership.

Institutional and Insider Ownership

89.4% of Illumina shares are owned by institutional investors. 2.9% of Illumina shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares Illumina and Parallax Health Sciences”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Illumina	$4.34 billion	6.71	$850.00 million	$5.36	35.99
Parallax Health Sciences	N/A	N/A	N/A	N/A	N/A

Illumina has higher revenue and earnings than Parallax Health Sciences.

Analyst Ratings

This is a summary of recent ratings and target prices for Illumina and Parallax Health Sciences, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Illumina	2	6	8	1	2.47
Parallax Health Sciences	0	0	0	0	0.00

Illumina currently has a consensus target price of $188.40, indicating a potential downside of 2.34%. Given Parallax Health Sciences’ higher possible upside, analysts plainly believe Parallax Health Sciences is more favorable than Illumina.

Profitability

This table compares Illumina and Parallax Health Sciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Illumina	18.36%	29.84%	12.17%
Parallax Health Sciences	N/A	N/A	N/A

Summary

Illumina beats Parallax Health Sciences on 9 of the 10 factors compared between the two stocks.

About Illumina

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.

About Parallax Health Sciences

Parallax Health Sciences, Inc. is an integrated digital healthcare company. It is engaged in the provision of personalized patient care through remote healthcare services, behavioral health systems, and Point-of-Care diagnostic testing. The firm operates through the following segments: Remote Patient Monitoring, Behavioral Health Systems, and Corporate. The Remote Patient Monitoring segment offers a technology platform that includes a complete remote patient care delivery system through PHM. The Behavioral Health Systems segment includes the intellectual property, Reliable Evidence-Based Outcomes Optimization Technologies, through its wholly-owned subsidiary, Parallax Behavioral Health, Inc. The Corporate segment consists of management and administrative services. The company was founded on July 6, 2005 and is headquartered in Los Angeles, CA.